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CD8+ T cells confer host protection through T-cell-
receptor (TCR)-mediated recognition of foreign anti-
gens presented by infected cells. Thus, generation of
CD8+ T cell populations with high antigen sensitivity
is critical for efficient pathogen clearance. Besides
selection of high-affinity TCRs, the molecular mech-
anisms regulating the antigen sensitivity of CD8+
T cells remain poorly defined. Herein, we have
demonstrated that the antigen sensitivity of effector
and memory CD8+ T cells is dynamically regulated
and can be tuned by pathogen-induced inflammatory
milieux independently of the selection of cells with
higher TCR affinity. Mechanistically, we have demon-
strated that the signal-transduction capacity of key
TCR proximal molecules is enhanced by inflamma-
tory cytokines, which reduced the antigen density
required to trigger antimicrobial functions. Dynamic
tuning of CD8+ T cell antigen sensitivity by inflam-
matory cytokines most likely optimizes immunity
to specific pathogens while minimizing the risk of
immunopathology at steady state.
INTRODUCTION
The capacity to clear infection relies on both the quantity and the
quality of responding immune cells (Haring et al., 2006; Walker
et al., 2010; Zhang and Bevan, 2011). Protection by CD8+
T cells against intracellular pathogens strongly correlates with
their ability to respond to low antigen density (high antigen
sensitivity) (Alexander-Miller, 2005). Conversely, highly sensitive
T cells could be detrimental for the host, resulting in immuno-
pathology or autoimmunity (Amrani et al., 2000; Han et al.,
2005). As such, the antigen sensitivity of CD8+ T cells must be
tightly regulated.
Although B cells enhance antigen sensitivity through somatic
hypermutation of the B cell receptor, individual T cells are unable
to directly change the binding affinity of their T cell receptor
(TCR). However, increases in antigen sensitivity (also termed
functional avidity [Slifka and Whitton, 2001]) occur during T cell140 Immunity 38, 140–152, January 24, 2013 ª2013 Elsevier Inc.responses (Busch and Pamer, 1999; Malherbe et al., 2004;
Zehn et al., 2009). During infection or immunization, higher-
avidity CD8+ T cell clones, compared to lower-avidity clones,
sustain proliferation, thus enhancing antigen sensitivity of the
population (Zehn et al., 2009). Interestingly, monoclonal TCR
transgenic (tg) CD8+ T cells also increase their antigen sensitivity
as they progress from early to late effector stages after infection
(Slifka and Whitton, 2001). Thus, T cell intrinsic properties,
unrelated to repertoire selection, can also control the antigen
sensitivity of CD8+ T cells. Together, these studies underscore
the possibility that antigen sensitivity of individual CD8+ T cells
might be dynamically regulated independently of changes in
TCR utilization. However, the molecular mechanisms regulating
antigen sensitivity of effector CD8+ T cells remain poorly under-
stood. Additionally, it remains unknown whether functional
avidity maturation is hardwired in cells with a specific TCR (Slifka
and Whitton, 2001) or whether antigen sensitivity can be modu-
lated by pathogen-specific signals.
Inflammatory cytokines provide an additional signal that,
along with TCR ligation and costimulation, is required for
maximal effector CD8+ T cell accumulation (Curtsinger and
Mescher, 2010; Curtsinger et al., 1999; Curtsinger et al., 2005).
The inflammatory cytokines permitting optimal CD8+ T cell
responses depend on the inflammatory milieu induced by
the invading pathogen (Aichele et al., 2006; Kolumam et al.,
2005; Pearce and Shen, 2007). The inflammatory environments
induced by infection also sustain effector differentiation and
delay the formation of functional memory CD8+ T cells (Badovi-
nac et al., 2005; Haring et al., 2006; Joshi et al., 2007; Joshi and
Kaech, 2008; Pham et al., 2009). In contrast, immunization with
peptide-coated mature dendritic cells (DCs) in the absence of
systemic inflammation induces CD8+ T cells that rapidly acquire
memory characteristics (Badovinac et al., 2005; Pham et al.,
2009). Given that the inflammatory milieu plays multiple roles in
regulating the T cell response, we tested the hypothesis that
inflammatory cytokines directly regulate antigen sensitivity of
CD8+ T cells independently of clonal selection.
RESULTS
Infection-Induced Inflammatory Milieux Regulate
Antigen Sensitivity of Endogenous Effector CD8+ T Cells
To determine whether the inflammatory milieu regulates the
antigen sensitivity of effector CD8+ T cells, we immunized mice
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Inflammation Regulates T Cell Antigen Sensitivitywith lipopolysacharide (LPS)-matured DCs coated with oval-
bumin257–264 (OVA) peptide (DC-OVA) in the presence or
absence of infection with attenuated Listeria monocytogenes
(LM) or lymphocytic choriomeningitis virus strain Armstrong
(LCMV). Infection with LM or LCMV, which do not express
OVA, induces multiple inflammatory cytokines (Biron, 1999;
Pamer, 2004). This system allowed us to study the effect of
the pathogen-specific inflammatory milieu in a setting where
antigen presentation remains constant (Badovinac et al., 2005;
Pham et al., 2009).
Antigen sensitivity of endogenous OVA-specific CD8+ T cells
was measured on day 5 after DC immunization by ex vivo stim-
ulation with titrated doses of OVA peptide, and the cells were
subsequently intracellularly stained for effector cytokines. We
evaluated antigen sensitivity on day 5 because pathogen clear-
ance occurs before peak CD8+ T cell numbers and because
the effector function of CD8+ T cells at early time points is
therefore critical to an effective immune response (Badovinac
et al., 2002; Pope et al., 2001). We observed that infection with
either LM or LCMV significantly (p < 0.01 and p < 0.001, respec-
tively) increased the antigen sensitivity of the responding OVA-
specific CD8+ T cells, as determined by the percentage of cells
producing interferon-g (IFN-g) (Figures 1A and 1B). Compared
with that of OVA-specific CD8+ T cells from mice immunized
with only DC-OVA, the antigen sensitivity of OVA-specific
CD8+ T cells was increased 2.9-fold with LM infection and
10.7-fold with LCMV infection (Figure 1B), as measured by the
peptide concentration required for obtaining 50% of the
maximum IFN-g production (effective concentration 50 [EC50])
(Figure 1B). In addition, exposure to inflammation significantly
(p < 0.01 and p < 0.001 for LM and LCMV, respectively)
increased IFN-g production per cell (Figure 1C and Figure S1A,
available online). Thus, the inflammatory milieu induced by
infection enhanced antigen sensitivity of OVA-specific effector
CD8+ T cells. The inflammatory milieu associated with LCMV
infection resulted in a higher sensitivity to antigen than did LM
infection. Thus, the antigen sensitivity of early effector CD8+
T cells was tuned in a pathogen-specific manner.
Antigen Sensitivity Can Be Regulated Independently
of Clonal Selection
The preceding analyses of endogenous effector CD8+ T cells did
not distinguish whether enhanced antigen sensitivity depends
on the selection of high-affinity T cells. To address this, we
sought to determine whether infection-associated inflammation
increases antigen sensitivity of monoclonal TCR tg CD8+
T cells. Physiologic numbers of Thy1.1/1.1 or Thy1.1/1.2 OVA-
specific OT-I TCR tg CD8+ T cells were adoptively transferred
into Thy1.2/1.2 mice. We immunized recipients 24 hr later with
DC-OVA in the presence or absence of LM or LCMV infection
to induce pathogen-specific inflammation. To control for poten-
tial effects of infection on the function of antigen-presenting cells
(APCs) during ex vivo stimulation, we stimulated congenically
marked OT-I cells from the DC-OVA-only group in the same
well as OT-I cells from mice immunized with DC-OVA in the
presence of LM or LCMV infection. As a result of the fixed TCR
and common APC pool in this scenario, any observed differ-
ences in antigen sensitivity between groups must be T cell
intrinsic. We observed that infection with LM or LCMV also sig-nificantly (p < 0.05 and p < 0.001, respectively) increased the
antigen sensitivity of monoclonal OT-I CD8+ T cells on day 5 after
immunization (Figures 1D and 1E). Measured by the EC50 of
peptide required for IFN-g production, the antigen sensitivity of
OT-I CD8+ T cell IFN-g production was 2.4-fold higher with LM
infection and 7.6-fold higher with LCMV infection than that of
OT-I CD8+ T cells generated with DC-OVA alone (Figure 1E).
Similarly, LM and LCMV infection enhanced the antigen sensi-
tivity for the production of OT-I tumor necrosis factor a (TNF-a)
(Figures S1C and S1D). This increase in antigen sensitivity
permitted robust cytokine production at antigen concentrations
that were insufficient to induce a cytokine response from OT-I
CD8+ T cells generated by DC-OVA immunization alone. As
observed with endogenous responses, LCMV infection exerted
a greater effect than did LM infection on OT-I CD8+ T cell antigen
sensitivity and the per cell production of IFN-g (Figures 1E and 1F
and Figure S1B). These data show that the pathogen-specific
inflammatory milieu regulates antigen sensitivity of CD8+
T cells for effector-cytokine production independently of clonal
selection or APC function.
Inflammatory cytokines are rapidly produced after infection
and could exert their effects by altering priming of naive CD8+
T cells. To address this, we infected mice with LCMV at day 3
after DC-OVA immunization, a time point when priming of new
T cells by DC immunization is not detectable (Badovinac et al.,
2005; Prlic et al., 2006). Infection with LCMV on day 3 postimmu-
nization still significantly enhanced (p = 0.015) the antigen
sensitivity of OT-I CD8+ T cells for IFN-g production at day 5
by 5.6-fold, as measured by EC50 (Figures 1G and 1H). Thus,
the infection-induced inflammatory milieu rapidly influences
antigen sensitivity of CD8+ T cells independently of the effects
on priming.
We next determined whether inflammation simply accelerates
acquisition of peak antigen sensitivity by CD8+ T cells or also
enhances antigen sensitivity for prolonged periods. Infection
with LM or LCMV resulted in significantly higher antigen
sensitivity (p = 0.0003 and p = 0.004, respectively) and per cell
IFN-g production (p = 0.0027 and p = 0.0019, respectively) in
OT-I CD8+ T cells on day 8 postimmunization than in OT-I
CD8+ T cells generated by DC-OVA alone (Figure 2 and Fig-
ure S2). Comparison of the EC50 values for IFN-g production
by OT-I cells in the presence of LCMV infection revealed lower
antigen sensitivity at day 8 (EC50 = 44 pM) (Figure 2E) than at
day 5 (EC50 = 21 pM) (Figure 1F). Thus, the antigen sensitivity
of CD8+ T cells exposed to a pathogen-specific inflammatory
milieu can be dynamically regulated to peak early after infection
and then decrease as the infection is resolved.
Infection-Induced Inflammatory Milieu Enhances
Cytolysis by CD8+ T Cells
In addition to effector cytokines, CD8+ T cells are cytolytic
through the perforin and granzyme B granule-exocytosis path-
ways. OT-I CD8+ T cells from mice immunized with DC-OVA
and LM or LCMV expressed more granzyme B (Figure 3A) and
also exhibited a decreased EC50 of OVA peptide required for
degranulation (as measured by surface CD107a expression,
Figures 3B and 3C). Consistent with these data, OT-I T cells
primed in mice receiving LCMV infection exhibited significantly
(p = 0.026 and p = 0.023) enhanced per cell in vivo killing ofImmunity 38, 140–152, January 24, 2013 ª2013 Elsevier Inc. 141
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Figure 1. Pathogen-Specific Inflammation Increases Antigen Sensitivity of Effector CD8+ T Cells
(A) The percentage of IFN-g+ endogenous CD8+ T cells at day 5 after immunization with DC-OVA alone (gray squares) or DC-OVA coinfected with LM (open
circles) or LCMV (black triangles) was determined after ex vivo stimulation with titrated concentrations of OVA peptide. Data (mean ± SEM) are normalized to the
percentage of IFN-g+ cells at peptide saturation (200 nM).
(B) Summary (mean ± SEM) of EC50 for stimulation of IFN-g production by endogenous OVA-specific CD8
+ T cells.
(C) Geometric mean fluorescence intensity (gMFI) (mean ± SEM) of IFN-g by endogenous OVA-specific CD8+ T cells at peptide saturation (200 nM).
(D–F) The same as (A)–(C), respectively, but for OT-I CD8+ T cells (saturating peptide = 10 nM).
(G and H) The same as (A) and (B), respectively, but for OT-I CD8+ T cells after LCMV infection on day 3 after immunization with DC-OVA.
Data in (A), (C), (D), (F), and (G) are from three mice per group and are representative of at least two independent experiments. Data in (B), (E), and (H) are
cumulative from two to three independent experiments with at least sixmice per group. Data in (B), (C), (E), and (F) were analyzed by one-way ANOVAwith Tukey’s
post-test of multiple comparisons. Data in (H) were analyzed with a two-tailed, unpaired Student’s t test. See also Figure S1.
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Inflammation Regulates T Cell Antigen Sensitivitysplenocytes coated with two doses of OVA peptide (Figures 3D
and 3E). Thus, the inflammatory milieu regulates the in vivo
capacity of effector CD8+ T cells to kill targets displaying low
amounts of antigen.
Inflammation Enhances TCR Signaling
To address underlying mechanisms of inflammation-induced
T-cell-intrinsic increases in antigen sensitivity, we initially ruled142 Immunity 38, 140–152, January 24, 2013 ª2013 Elsevier Inc.out changes in surface expression of the alpha (Va2) and beta
(Vb5) chains of the TCR or CD3ε, the costimulatory molecule
CD28, or CD11a (the a chain of LFA-1, a critical integrin that
facilitates conjugation between T cells and DCs [Dustin et al.,
1989]) (Figure 4A). However, we did observe that the sensitivity
of IFN-g production to plate-bound CD3 antibody was 5.3-fold
higher in OT-I cells primed in the presence of LCMV-induced
inflammation than in OT-I cells immunized with DC-OVA alone
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Figure 2. Infection-Induced Inflammation Enhances Antigen Sensitivity of CD8+ T Cells for Several Days
(A) The percentage of IFN-g+ OT-I CD8+ T cells at day 8 after immunization with DC-OVA alone (gray square) or DC-OVA and LM (open circles) was determined
after ex vivo stimulation with titrated concentrations of OVA peptide. Data are normalized as in Figure 1 except that peptide saturation was 10 nM.
(B) Summary (mean ± SEM) of EC50 for stimulation of IFN-g production by OT-I CD8
+ T cells.
(C) gMFI (mean ± SEM) of IFN-g expressed by OT-I CD8+ T cells at peptide saturation (10nM).
(D–F) The same as (A)–(C), respectively, but for OT-I CD8+ T cells on day 8 after immunization with DC-OVA alone (gray squares) or DC-OVA and LCMV
(black triangles).
Data in (A), (C), (D), and (F) are from three mice per group and are representative of two independent experiments. Data in (B) and (E) are cumulative from two
independent experiments with at least six mice per group. Data were analyzed with a two-tailed, unpaired Student’s t test. See also Figure S2.
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Inflammation Regulates T Cell Antigen Sensitivity(Figure 4B). These data suggest that inflammation regulates
antigen sensitivity by increasing the capacity to translate
TCR signals rather than by enhancing APC or costimulatory
interactions.
Ligation of the TCR results in the activation of a signaling
cascade initiated by the tyrosine kinases LCK and ZAP-70.
Studies have suggested that enhanced antigen sensitivity
following infection might be regulated by increased expression
of these key signaling molecules (Amoah et al., 2012; Slifka
and Whitton, 2001). However, exposure to inflammation did
not increase the protein expression of either of these kinases
at day 5 postimmunization (as measured by the relative signal
intensity compared to the b-actin loading control) (Figures 4C
and 4D and Figures S3A and S3B). Therefore, we assessed
whether inflammation increased antigen sensitivity of CD8+
T cells by enhancing their capacity to translate TCR signals.
CD3-antibody stimulation resulted in enhanced and more rapid
phosphorylation of ZAP-70 in CD8+ T cells exposed to inflam-
mation than in OT-I CD8+ T cells from mice immunized with
DC-OVA alone (Figure 4D and Figure S3C). Thus, CD8+ T cellsexposed to inflammation exhibit enhanced activation of ZAP-
70 after TCR stimulation, which occurs independently of
changes in total LCK or ZAP-70.
Phosphorylation of ZAP-70 leads to the activation of phos-
pholipase C g (PLC)-g, which cleaves phosphatidylinositol
4,5-bisphosphate (PIP2) into the secondary messengers inositol
1,4,5-triphosphate (IP3) and diacylglycerol (DAG). These
secondary messengers initiate intracellular calcium release
and the activation of protein kinase C (PKC) and the mitogen-
activated protein kinase (MAPK) pathway, resulting in the
transcription of target genes, including IFN-g (Abraham and
Weiss, 2004; Smith-Garvin et al., 2009). We observed an
increase in the phosphorylation of PLC-g on activating tyrosine
783 in CD8+ T cells exposed to inflammation (Figure 4E and
Figure S3D), demonstrating that exposure to inflammation
enhanced the activation of signaling pathways downstream of
TCR ligation. This led to dramatic increases in the activation of
PLC-g-dependent MAPK pathways (Nolz et al., 2006), as shown
by the marked enhancement in the phosphorylation of extra-
cellular-signal-regulated kinases 1 (ERK1) and 2 (ERK2) andImmunity 38, 140–152, January 24, 2013 ª2013 Elsevier Inc. 143
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Figure 3. Infection-Induced Inflammation Enhances Cytolysis by
CD8+ T Cells
(A) Representative plots of granzyme B expression at day 5 after DC-OVA
immunization with or without LM or LCMV infection. Shaded histograms
are isotype controls. Numbers show gMFI of granzyme B staining. Data
are representative of at least three mice per group and two independent
experiments.
(B) The percentage of CD107a+ OT-I CD8+ T cells at day 5 after immunization
with DC-OVA alone (gray square) or DC-OVA coinfected with LM (open circles)
or LCMV (black triangles) was measured after ex vivo stimulation with titrated
concentrations of OVA peptide. Data (mean ± SEM) are normalized as in
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144 Immunity 38, 140–152, January 24, 2013 ª2013 Elsevier Inc.c-Jun N-terminal kinases 1 (JNK1) and 2 (JNK2) in CD3-stimu-
lated CD8+ T cells exposed to inflammation (Figures 4F and 4G
and Figures S3E and S3F). We did not observe enhanced phos-
phorylation of another MAPK, p38 (Figures S3G and S3H). In
T cells, p38 can be activated in a noncanonical manner indepen-
dent of linker of activated T cells (LAT) (Salvador et al., 2005).
These data suggest that exposure to inflammation specifically
enhances the canonical MAPK activation pathway. In contrast,
we saw no differences in ERK1 and ERK2 activation when cells
were stimulated with phorbol myristate acetate (PMA), a DAG
analog that activates the MAPK pathway and phosphorylation
of ERK1 and ERK2while bypassing the requirement for TCR liga-
tion and proximal signaling events (Figure 4H). Thus, although
CD8+ T cells stimulated with DC-OVA in a noninflammatory
milieu were capable of robust MAPK activation, exposure of
these cells to pathogen-induced inflammation enhanced TCR
proximal signaling, amplified MAPK activation, and increased
antigen sensitivity.
To determine whether the enhanced TCR signaling controlled
antigen sensitivity in cells exposed to inflammation, we evalu-
ated IFN-g production from cells stimulated with either OVA
peptide or PMA and ionomycin. We observed a larger fold
increase in per cell IFN-g production by OT-I T cells exposed
to inflammation after peptide stimulation than in OT-I T cells
exposed to inflammation after stimulation with PMA and ionomy-
cin (Figure 4I). These data confirm that exposure to inflammation
increases antigen sensitivity by enhancing proximal TCR
signaling.
Direct Regulation of Antigen Sensitivity by Inflammatory
Cytokines
Pathogens elicit distinct and complex inflammatory-cytokine
responses. For example, LM infection induces several cytokines,
including interleukin-12 (IL-12) and type 1 interferon, whereas
LCMV elicits a dominant type 1 interferon response (Biron,
1999; Pamer, 2004). As such, we sought to determine whether
regulation of antigen sensitivity by exposure to inflammation
requires direct signaling to CD8+ T cells by specific cytokines.
Congenically marked wild-type (WT) OT-I CD8+ T cells and
OT-I CD8+ T cells deficient in IL-12 receptor b1 (Il12rb1/)
were cotransferred into WT mice, which were immunized with
DC-OVA in the presence or absence of infection with LM or
LCMV. Compared to WT OT-I CD8+ T cells, Il12rb1/ OT-I
CD8+ T cells responded to immunization with DC-OVA alone
and did not exhibit changes in antigen sensitivity (Figure 5A).
However, antigen sensitivity of Il12rb1/ OT-I CD8+ T cells in
mice receiving LM infection was significantly (p = 0.004) lowerFigure 1 except that peptide saturation was 10 nM. Data are from three mice
per group and are representative of two independent experiments.
(C) Summary (mean ± SEM) of EC50 for degranulation (CD107a staining) of
OT-I CD8+ T cells. Data are cumulative from two independent experiments
with a total of six mice per group and were analyzed by one-way ANOVA
with Tukey’s post-test of multiple comparisons.
(D) The percentage of in-vivo-specific killing of splenocytes coated with
0.05 nM OVA peptide. Data are the percentage of killing for 13 106 OT-I CD8+
T cells in recipient mice. Data are from at least four mice per group, are
representative of two independent experiments, and were analyzed with
a two-tailed, unpaired Student’s t test.
(E) The same as (D) but for splenocytes coated with 0.025 nM OVA peptide.
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signaling directly regulates the antigen sensitivity of CD8+
T cells. Despite this, the LM-induced inflammatory milieu still
partially increased the antigen sensitivity of Il12rb1/ OT-I
CD8+ T cells (Figures 5A and 5B), indicating that IL-12 is not
the only cytokine involved in modulating the antigen sensitivity
of responding CD8+ T cells after LM infection. Il12rb1/ and
WT OT-I cells exhibited the same enhancement of antigen
sensitivity after DC-OVA immunization in the presence of
LCMV infection (which primarily drives type 1 interferon and
not IL-12) (Figure 4C).
To address a role for type 1 interferon signaling and extend our
results to an additional TCR tg CD8+ T cell, we cotransferred
congenically marked WT P14 (specific to the GP33-41 epitope
of LCMV) CD8+ T cells and P14 CD8+ T cells deficient in type 1
interferon receptor (Ifnar1/) into WT mice, which were immu-
nized with DC-GP33 and subsequently infected with LM or
Pichinde virus (PV) on day 3 postimmunization. PV is an arenavi-
rus that does not express the GP33-41 epitope of LCMV. Infec-
tion with either LM or PV enhanced the antigen sensitivity of
WT P14 CD8+ T cells (Figures 5D–5F), whereas the absence of
the type 1 interferon receptor strongly abrogated the enhanced
antigen sensitivity of P14 CD8+ T cells in PV-infected mice
(Figure 5F). Thus, direct type 1 interferon signaling on CD8+
T cells plays a major role in the enhanced antigen sensitivity
associated with the exposure to PV-induced inflammation.
Deficiency of type 1 interferon receptor did not affect the
capacity of LM to enhance the antigen sensitivity of P14 CD8+
T cells, suggesting that although type 1 interferons are induced
by LM infection (Pamer, 2004), these cytokines do not play
a dominant role in regulating antigen sensitivity over the course
of this bacterial infection. Collectively, these data demonstrate
that inflammatory cytokines directly regulate the antigen sensi-
tivity of effector CD8+ T cells in a pathogen-specific manner.
To determine whether direct cytokine signaling on CD8+
T cells causes enhanced TCR signaling, we cotransferred con-
genically marked WT and Ifnar1/ P14 CD8+ T cells into WT
mice and immunized them with DC-GP33 with or without
infection with PV on day 3 after DC-GP33 immunization. Two
days later, phosphorylation of ERK1 and ERK2 after CD3
stimulation was analyzed by flow cytometry, which allowed
us to compare WT and Ifnar1/ T cells immunized in the
same mice. As described for WT OT-I CD8+ T cells (Figure 4),
exposure to inflammation enhanced ERK1 and ERK2 phos-
phorylation after stimulation of WT P14 CD8+ T cells (Figures
5G and 5H). Enhanced ERK1 and ERK2 activation was abro-
gated in Ifnar1/ P14 cells (Figures 5G and 5H). ERK1 and
ERK2 phosphorylation in Ifnar1/ P14 cells was similar to
that in WT P14 cells when proximal TCR signaling was by-
passed by PMA stimulation, demonstrating that Ifnar1/ cells
retain the capacity to signal normally (Figure 5H). These
data demonstrate that inflammatory cytokines act directly on
effector CD8+ T cells to enhance proximal TCR signaling and
increase antigen sensitivity.
Inflammatory Cytokines Enhance Antigen Sensitivity
of Memory CD8+ T Cells
Hosts will contain memory CD8+ T cells specific to multiple
pathogens, and these cells enhance immunity to pathogen re-exposure. To determine whether inflammatory cytokines also
enhance antigen sensitivity of memory CD8+ T cells, we infected
mice containing memory OT-I or P14 CD8+ T cells with an unre-
lated pathogen to induce inflammatory cytokines in the absence
of antigen stimulation (LCMV or PV, respectively). On day 4 after
infection, we observed that exposure to inflammatory cytokines
significantly increased the antigen sensitivity of memory OT-I
CD8+ T cells (Figures 6A and 6B) and memory P14 CD8+
T cells (Figures 6C and 6D) (p = 0.0026 and p = 0.0017, respec-
tively), as well as the per cell IFN-g production (Figure S3). Thus,
antigen sensitivity of memory CD8+ T cells was also regulated
by inflammatory cytokines. This change does not require
recent TCR stimulation, suggesting that inflammatory cytokines
enhance antigen sensitivity of memory cells prior to their poten-
tial interaction with cells expressing cognate antigen.
Chemokines induced by tissue-specific inflammation mediate
rapid, antigen-independent recruitment of memory CD8+ T cells
(Ely et al., 2003; Kohlmeier et al., 2008). To determine whether
tissue-specific inflammation enhances antigen sensitivity, we
infected mice harboring memory OT-I CD8+ T cells intranasally
with LCMV to induce inflammatory cytokines and recruitment
of memory cells to the lung. On day 3 after infection, lung OT-I
cells exposed to inflammation exhibited significantly (p =
0.0097) increased antigen sensitivity (Figure 6E), indicating
that exposure to inflammatory cytokines regulated the antigen
sensitivity of memory cells localized within the inflamed tissue.
Given that inflammatory cytokines tuned the antigen sensi-
tivity of memory CD8+ T cells independently of antigen re-
encounter, we next sought to determine whether tuning is
dynamic and antigen sensitivity returns to steady state after
clearance of infection. Mice containing memory OT-I CD8+ cells
were mock infected or infected with LCMV either 14 days or
4 days before the analysis such that antigen sensitivity in all
groups could be measured on the same day. Although OT-I
cell antigen sensitivity was significantly (p < 0.05) enhanced on
day 4 postinfection, this increase was transient because antigen
sensitivity was no longer significantly different from mock-
infected mice on day 14 after LCMV infection (Figure 6F). Thus,
tuning of memory CD8+ T cell antigen sensitivity is dynamic,
and in the absence of antigen re-encounter, antigen sensitivity
of bystander memory CD8+ T cells returns to steady state.
Inflammatory Cytokines Enhance TCR Signaling
of Memory CD8+ T Cells
To determine whether inflammatory cytokines increase antigen
sensitivity by enhancing TCR signaling, we purified memory
OT-I TCR tg CD8+ T cells on day 4 after LCMV infection or
mock infection and stimulated them by CD3 crosslinking. The
relatively low frequency of memory CD8+ T cells generated
from physiologic naive cell input numbers and low protein yield
precluded analysis of ZAP-70 phosphorylation. However, as
seen with effector CD8+ T cells, exposure to inflammation re-
sulted in dramatically increased phosphorylation of ERK1 and
ERK2 after TCR ligation (Figures 7A and 7B). This difference in
ERK1 and ERK2 phosphorylation was no longer observed
when TCR proximal signaling was bypassed with PMA (Fig-
ure 7C), demonstrating that exposure to inflammatory cytokines
also enhanced proximal TCR signaling in memory CD8+ T cells.
Collectively, these data demonstrate that inflammatoryImmunity 38, 140–152, January 24, 2013 ª2013 Elsevier Inc. 145
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Immunity
Inflammation Regulates T Cell Antigen Sensitivitycytokines tune antigen sensitivity by regulating TCR signaling of
both effector and memory CD8+ T cells.
DISCUSSION
Generation of highly sensitive CD8+ T cell clones is important for
the clearance of pathogen-infected cells, which can express low
amounts of antigen (Alexander-Miller, 2005; Walker et al., 2010).
Herein, we have demonstrated that inflammatory cytokines
directly regulate the antigen sensitivity of CD8+ T cells indepen-
dently of clonal selection. Our data have highlighted that the
antigen sensitivity of CD8+ T cells is not hardwired but rather is
dynamically regulated in a pathogen-specific manner. Further,
we have demonstrated that exposure to inflammatory cytokines
enhances TCR signaling of early effector and preexisting
memory CD8+ T cells to control antigen sensitivity. Dynamic
tuning of TCR signaling by pathogen-specific inflammatory cyto-
kines most likely represents an important regulatory mechanism
for the induction of optimal CD8+ T cell immunity.
Inflammatory cytokines provide a third signal that is required
for optimal accumulation of effector CD8+ T cells (Curtsinger
and Mescher, 2010; Curtsinger et al., 1999; Curtsinger et al.,
2005) and for sustaining effector differentiation (Badovinac
et al., 2005; Joshi et al., 2007; Joshi and Kaech, 2008; Pham
et al., 2009). Here, we have extended the role of these inflam-
matory cytokines by demonstrating their capacity to modulate
the antigen sensitivity of individual CD8+ T cell clones. We
have shown that the magnitude of increase in antigen sensitivity
of the same CD8+ T cell clone varies depending on the inflam-
matory milieu induced by the pathogen used for infection.
Thus, the precise pattern of inflammatory cytokines induced by
infection can help tune antigen sensitivity in order to achieve
optimal CD8+ T cell responses.
The rapid induction of peak antigen sensitivity by inflammatory
cytokinesmight be of critical importance for the efficient elimina-
tion of pathogens. CD8+ T cells with high antigen sensitivity are
of particular importance for the clearance of viral pathogens.
For example, patients that clear hepatitis C virus infection
contain CD8+ T cells with higher antigen sensitivity than do
CD8+ T cells harvested from chronically infected patients (Yerly
et al., 2008). Here, we have demonstrated that induction of
inflammation with a viral pathogen, LCMV, results in a nearly
10-fold increase in the antigen sensitivity of OT-I CD8+ T cells
and allows for more efficient in vivo killing of targets coated
with a low density of antigen. Such increases in antigen sensi-
tivity could allow antigen-specific CD8+ T cells to carry out
effector function more efficiently during the course of infection
by targeting cells when they are expressing lower amounts of
antigen. This could be of particular importance because many
viral pathogens are known to interfere with major-histocompati-
bility-complex class I trafficking and expression, and this
interference would lead to lower amounts of cognate antigen ex-
pressed on infected cells (Donaldson and Williams, 2009; Griffin(I) Summary fold increase in gMFI of IFN-g expression after stimulation with OVA p
compared to the mean gMFI of IFN-g production by OT-I CD8+ transgenic T
independent experiments with at least six mice per group.
See also Figure S3.et al., 2010; Jackson et al., 2011). It should be noted that,
although exposure of responding CD8+ T cells to inflammation
enhanced antigen sensitivity, this was balanced by the fact
that these cells were slower to acquire memory characteristics,
including the capacity for robust secondary expansion, than
were cells primed in a low-inflammatory environment (Badovinac
et al., 2005; Haring et al., 2006). As such, although enhanced
antigen sensitivity might represent a significant advantage for
short-term protection, the consequences of these changes for
long-term protection and memory will require further study and
must be considered during therapy design or the development
of vaccine strategies.
It has previously been established that tissue-specific infec-
tion results in nonspecific recruitment of memory T cells to in-
flamed sites (Ely et al., 2003; Kohlmeier et al., 2008). We have
demonstrated that exposure to inflammatory cytokines also
dynamically enhances the antigen sensitivity of memory CD8+
T cells in the absence of antigen re-encounter in both the spleen
and peripheral tissue. This suggests that infection enhances
the antigen sensitivity of memory CD8+ T cells regardless of
their antigen specificity, thus preparing these cells for rapid
deployment of effector functions should they encounter cells
expressing low amounts of cognate antigen. Rapid enhance-
ment in antigen sensitivity might in part explain why memory
T cells respond to an invading pathogen by producing effector
cytokines within hours of infection (Whitmire et al., 2008).
Bystander activation of memory CD8+ T cells also occurs during
acute infection in humans, suggesting that this represents
a conserved regulatory mechanism for optimal memory CD8+
T cell function (Odumade et al., 2012).
A previous study suggested that antigen exposure results in
hardwired TCR-signaling-pathway changes that increase
antigen sensitivity in a temporal fashion (Slifka and Whitton,
2001). This conclusion was drawn during the evaluation of the
CD8+ T cell response to a single pathogen, and although some
changes in TCR signaling are likely to occur solely as a result
of antigen exposure, our results show that TCR-signaling
capacity can be dynamically tuned by exposure to pathogen-
specific inflammatory cytokines in both effector and memory
CD8+ T cells. Indeed, we observed that inflammatory cytokines
rapidly and transiently enhance the antigen sensitivity of effector
CD8+ T cells. Similarly, we have shown that the antigen sensi-
tivity of a monoclonal population of memory CD8+ T cells can
be transiently increased after exposure to inflammation. This
demonstrates that the antigen sensitivity of circulating memory
T cells that do not re-encounter their cognate antigen is blunted
as inflammatory stimuli wane. As such, the modulation of the
antigen sensitivity of memory cells most likely represents an
important regulatory mechanism aimed at minimizing the risks
of immunopathology or autoimmunity.
One major question that remains is how inflammatory cyto-
kines modulate the signaling capacity of responding CD8+
T cells. Inflammatory cytokines induce the transcription of aeptide (10 nM) or PMA and ionomycin. Data are presented as the fold increase
cells from mice immunized with DC-OVA only. Data are cumulative of two
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Figure 6. Inflammatory Cytokines Enhance
the Antigen Sensitivity of Memory CD8+
T Cells
(A) The percentage of IFN-g+ memory OT-I CD8+
T cells at day 4 after infection with LCMV (black
triangles) or mock infection with saline (gray
squares) was determined after ex vivo stimulation
with titrated concentrations of OVA peptide. Data
are normalized as in Figure 1 except that peptide
saturation was 10 nM.
(B) Summary (mean ± SEM) of EC50 for IFN-g
production by memory OT-I CD8+ T cells.
(C and D) Same as (A) and (B), respectively, but for
memory P14 CD8+ T cells after ex vivo stimulation
with GP33-41 peptide on day 4 after infection with
PV (black triangles) or mock infection with saline
(gray squares).
(E) Same as (B) but for memory OT-I CD8+ T cells
isolated from the lung at day 3 after intranasal
infection with LCMV (black triangles) or mock
infection with saline (gray squares). Saturating
peptide = 10 nM.
(F) Same as (B) but for memory OT-I T cells on
day 4 (black bars) or day 14 (white bars) after
infection with LCMV or mock infection with saline
(gray bars).
Data in (A) and (C)–(E) are from three mice per
group and are representative of at least two inde-
pendent experiments. Data in (B) and (F) are
cumulative from at least two independent experi-
ments with at least six mice per group. Data in (B),
(D), and (E) were analyzed with a two-tailed,
unpaired Student’s t test. Data in (F) were analyzed
by one-way ANOVA with Tukey’s post-test of
multiple comparisons. See also Figure S4.
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Inflammation Regulates T Cell Antigen Sensitivityvariety of genes, including those encoding transcription factors,
and could lead to changes in the expression of key signaling
components (Agarwal et al., 2009; Joshi et al., 2007; Pipkin
et al., 2010). Slifka and Whitton (2001) reported a correlation
between the amount of total LCK expression and the amount
of IFN-g per CD8+ T cells. They suggested that the total ex-
pression of this signaling molecule might regulate antigen(G) Representative flow-cytometry plots of pERK1 and pERK2 from WT or Ifnar1/ P14 CD8+ T cells on day
PV infection on day 3. Cells were stimulated with either CD3-antibody crosslinking or PMA for the indicated
and are representative of two independent experiments.
(H) Summary data of the percentage of pERK1 and pERK2 from WT or Ifnar1/ P14 CD8+ T cells after activ
three pooled mice per group and are representative of two independent experiments.
Immunity 38, 140–152sensitivity of CD8+ T cells. However, we
have demonstrated that exposure to
inflammatory cytokines directly enhances
the signaling capacity of early effector
CD8+ T cells without increasing the total
expression of either LCK or ZAP-70.
This suggests that cytokine signaling to
CD8+ T cells enhances the activity of
signal-transducing molecules involved in
the TCR-signaling pathway. To this effect,
a recent study has demonstrated that
antigen stimulation of CD8+ T cells resultsin an increase in oligomeric TCR complexes (Kumar et al., 2011).
A contribution of inflammatory cytokines to the reorganization of
TCR complexes could explain the increased sensitivity of
memory T cells to antigen stimulation. Alternatively, exposure
to inflammatory cytokines might reduce the expression or
activity of negative TCR-signaling regulators, such as phospha-
tases. Resolving these issues will require further studies.5 after immunization with DC-GP33 with or without
times. Data are from three pooled mice per group
ation by CD3-antibody crosslinking. Data are from
, January 24, 2013 ª2013 Elsevier Inc. 149
0 2 5 0 2 5
pERK1,2
ERK1,2
β-actin
Saline LCMV
CD3 antibody
Time (min):
0 2
Saline
0 2
 LCMV
PMA
Time (min):
pERK1,2
ERK1,2
β-actin
BA
0 1 2 3 4 5
0
1
2
3
4 saline
LCMV
Time (min)
pE
R
K
1,
2/
To
ta
lE
R
K
1,
2
C
Figure 7. Inflammatory Cytokines Enhance TCR Signaling of Memory CD8+ T Cells
(A) Immunoblot analysis of cell lysates from memory OT-I CD8+ T cells on day 4 after infection with LCMV or mock infection with saline. Cells were stimulated
by CD3-antibody crosslinking as indicated. Equivalent amounts of protein were loaded in each lane. Samples were pooled from five to ten mice and are
representative of two independent experiments.
(B) The relative signal intensity of pERK1 and pERK2 is divided by the relative signal intensity of total ERK1 and ERK2. Data are normalized to the maximal
activation observed in memory CD8+ T cells from mock-infected mice. Samples were pooled from five to ten mice.
(C) The same as (A) but for cells stimulated with PMA.
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Inflammation Regulates T Cell Antigen SensitivityIn conclusion, TCR-signaling capacity can be directly regu-
lated by inflammatory cytokines, resulting in T-cell-intrinsic
increases in antigen sensitivity and in vivo cytolytic capacity.
Our study demonstrates that the antigen sensitivity of individual
CD8+ T cell clones is not hardwired after infection but rather is
a dynamic process dictated by the specific inflammatory milieu
induced by an invading pathogen. This most likely allows the
rapid generation of optimal effector and memory CD8+ T cell
responses while minimizing the risk of immunopathology.EXPERIMENTAL PROCEDURES
Mice, Pathogens, and Dendritic Cells
C57BL/6 mice were purchased from the National Cancer Institute (Frederick,
MD, USA). Mice with TCR tg OT-I cells and P14 cells were previously
described (Hogquist et al., 1994; Pircher et al., 1987). Il12rb1/ OT-I cells
were provided by Dr. Mescher (University of Minnesota), and Ifnar1/ P14
cells were provided by Dr. Murali-Krishna Kaja (Emory University). Infected
mice were housed at the appropriate biosafety level. The University of
Iowa Animal Care and Use Committee approved animal experiments. An
attenuated act-A-deficient strain of LM (DPL1942) (Brundage et al., 1993)
was grown and injected intravenously (i.v.) (1 3 106 colony-forming units
[cfu]) as described (Harty and Bevan, 1995). LCMV was propagated as
described (Slifka and Whitton, 2001) and injected intraperitoneally (i.p.) (2 3
105 plaque-forming units [pfu]). PV was propagated as described (Varga
et al., 2001) and injected i.p. (13 106 pfu). LPS-matured OVA-peptide-coated
DCs were prepared as previously described (Schmidt et al., 2008) and injected
i.v. (5 3 105).150 Immunity 38, 140–152, January 24, 2013 ª2013 Elsevier Inc.Adoptive Transfers and Generation of Memory Cells
Naive TCR tg CD8+ T cells (1 3 103 OT-I Thy1.1/1.1 or Thy1.1/1.2 cells) were
injected i.v. into naive Thy1.2 recipients. Mice were immunized 24 hr later with
DC-OVAwith or without infection with LM or LCMV. Il12rb1/ Thy1.2/1.2 OT-I
cells were mixed 1:1 with WT Thy1.1/1.1 OT-I cells (13 103 each) and injected
i.v. into naive CD45.1 recipients and immunized as indicated. Thy1.1/1.1
Ifnar1/ P14 cells were mixed 1:1 with WT Thy1.1/1.2 P14 cells (5 3 103
each), injected i.v. into naive Thy1.2/1.2 recipients, immunized with DC-
GP33 on day 0, and subsequently infected with LM or PV on day 3 postimmu-
nization. For generation of primary memory cells, naive Thy1.1 OT-I CD8+
T cells (5 3 102) or P14 CD8+ T cells (1 3 104) were injected i.v. into naive
Thy1.2 WT recipients infected with either actA/ LM OVA (5 3 106 cfu) or
LCMV (2 3 105 pfu). Mice were rested at least 50 days before use.
Ex Vivo Cytokine and Degranulation Analyses
Ex vivo cytokine detection and degranulation assays were performed as
previously described (Butler et al., 2012; Nolz and Harty, 2011) and as
detailed in the Supplemental Experimental Procedures. Where indicated,
congenically marked cells from DC-OVA only and coinfected groups were
mixed and stimulated in the same well. Titration curves were fitted by
nonlinear regression.
In Vivo Cytolytic Assay
Assay was performed as previously described (Schmidt et al., 2011). In brief,
splenocytes were left untreated or coated with OVA peptide (0.05 or
0.025 nM) for 1 hr at 37C. Splenocytes were labeled with 0.8 mM carboxy-
fluorescein succinimidyl ester (CFSE) (no peptide), 0.02 mM CFSE (0.05 nM
OVA), 2.5 mM CellTracker Violet (no peptide), or 0.25 mM (0.025 nM OVA).
Labeled cells (5 3 106 each, 2 3 107 total cells) were transferred i.v. into
recipient mice. Killing was measured in the spleen at 4 hr after transfer. The
Immunity
Inflammation Regulates T Cell Antigen Sensitivitykilling percentage was calculated as 100 (1003 [(% CFSEhi / %CFSElo) / (%
CFSEhi in naive mice / % CFSElo in naive mice)]) and is presented as the
normalized percentage of killing per 1 3 106 OT-I CD8+ T cells in recipient
mice.
TCR Signaling and Immunoblot Analysis
Naive Thy1.1 OT-I cells were injected i.v. (13 104) into naive Thy1.2 recipients,
which were immunized 24 hr later as indicated. On day 5, spleens were har-
vested, stained with PE-anti-Thy1.1 antibody (Clone OX-7, BD PharMingen),
and purified with PE-antibody magnetic beads according to standard
AutoMacs protocols. Memory OT-I CD8+ T cells were purified on day 4 after
LCMV infection or mock infection with saline. A total of 13 106 to 53 106 cells
were incubated on ice for 30 min with 10 mg/ml biotinylated CD3 antibody
(clone 145-2C11, eBioscience) and crosslinked with streptavidin or stimulated
with 200 ng/ml PMA for the indicated times at 37C. Cells were washed with
cold PBS and lysed in NP40 buffer (20 mM HEPES [pH 7.9], 100 mM NaCl,
5mMEDTA, 0.5mMCaCl, 1%Nonidet P-40, 1mMPMSF, 10 mg/ml leupeptin,
5 mg/ml aprotinin, and 1 mM Na3VO4). Five to ten micrograms of protein was
resolved by SDS-PAGE, transferred to nitrocellulose, and probed with anti-
bodies as indicated. Antibodies were detected with goat anti-rabbit conju-
gated to horseradish peroxidase (Santa Cruz) and Supersignal (Thermo
Scientific). Images were quantified with ImageJ software. Total-protein quan-
tification is presented as the ratio of the signal intensity of the protein of interest
to the signal intensity of b-actin and is normalized to the average ratio for
DC-OVA samples. Phosphorylation quantification is presented as the ratio of
the signal intensity of the phosphorylated protein of interest to the signal
intensity of total protein and is normalized to the maximal phosphorylation
in DC-OVA samples. Alternatively, ERK1 and ERK2 phosphorylation was
measured by flow cytometry. In brief, congenically marked WT or Ifnar1/
P14 CD8+ T cells (2.5 3 104) were adoptively transferred to naive recipients.
Mice were immunized with DC-GP33 with or without infection with PV on
day 3 postimmunization. Splenocytes were isolated on day 5 postimmuniza-
tion and stimulated with 10 mg/ml biotinylated CD3 antibody (clone 145-
2C11, eBioscience) and crosslinked with streptavidin for the indicated times
at 37C. Cells were fixed with BD cytofix (BD Bioscience), permeabilized
with BD Phosflow Perm Buffer III, and stained with an antibody specific to
pERK1 and pERK2 (T202 and Y204, respectively). Samples were analyzed
with a BDLSRFortessa flow cytometer (BD Bioscience) and flowjo software
(Tree Star).
Statistical Analyses
Data were analyzed with GraphPad Prism4 software. Specific tests for deter-
mining statistical significance are indicated in the figure legends.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at http://dx.doi.org/
10.1016/j.immuni.2012.09.017.
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